Moderna Inc (MIL:1MRNA)
€ 38.165 -0.445 (-1.15%) Market Cap: 14.61 Bil Enterprise Value: 9.32 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 44/100

Moderna, Inc. - Special Call Transcript

May 07, 2019 / 01:00PM GMT
StÃ;phane Bancel
Moderna, Inc. - CEO & Director

© -

Good morning, everybody, and thank you so much for joining us this morning. The team and I are very thrilled that you decided to spend the next few hours with us, and I know some of you are even going to spend the afternoon with us going to Norwood. So today is Science Day 2019. And we started last year [the rhythm of] doing an annual Science Day where we give a chance to our investors and analysts to look under the hood.

And I think you won't be disappointed with what Stephen, Melissa and the entire team are going to be sharing with you. What we'll try to do, given there's so much around the company, is to do a Science Day in the spring, to talk about the platform and all the advancements in the science. And then to do an R&D day in September, so that we can talk about the pipeline, and the different candidates and human data.

So today, we're talking about science. Of course, I have to start by reminding you that we're going to be making forward-looking statements, that there are many risks involved in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot